Christopher Bowd, Pfizer Inc. (F); Intae Lee, None; Felipe A. Medeiros, Alcon Laboratories Inc. (F, C, R), Allergan Inc. (C, R), Carl Zeiss Meditec Inc. (F, R), Merck Inc. (F), Pfizer Inc. (F, C, R), Reichert Inc. (R); Madhusudhanan Balasubramanian, None; Linda M. Zangwill, Carl Zeiss Meditec Inc. (F), Heidelberg Engineering GmbH (F, R), Optovue Inc. (F), Topcon Medical Systems Inc. (F); Christopher A. Girkin, Alcon Laboratories Inc. (C), Allergan Inc. (C), Carl Zeiss Meditec Inc. (R), Heidelberg Engineering GmbH (R), Merck Inc. (R), Optovue Inc. (R), Pfizer Inc. (C), Topcon Medical Systems Inc. (R); Jeffrey M. Liebmann, Alcon Laboratories Inc. (C), Allergan Inc. (C), Carl Zeiss Meditec Inc. (F), Dyopsis Corp. (F, C), Heidelberg Engineering GmbH (F), Optovue Inc. (F, C), Pfizer Inc. (C), Topcon Medical Systems Inc. (F, C); Robert N. Weinreb, Alcon Laboratories Inc. (C), Allergan Inc. (C), Carl Zeiss Meditec Inc. (F, C), Heidelberg Engineering GmbH (F), Merck Inc. (C), Novartis (F), Optovue Inc. (F, C), Pfizer Inc. (C), Topcon Medical Systems Inc. (F); Pamela A. Sample, Carl Zeiss Meditec Inc. (F), Haag-Streit AG (F); Michael H. Goldbaum, None